Director or Senior Director, Investor Relations and Corporate Communications
Lyell ImmunopharmaSouth San Francisco, California, United States · Posted 4 days agoDescription
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. And for patients with hematologic malignancies, there is a need for next-generation cell therapies that can deliver increased response rates and longer duration of response. We are a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with solid tumors or hematologic malignancies. Lyell’s product candidates are enhanced with novel technology designed to generate T cells that resist exhaustion and have qualities of durable stemness in order to drive durable tumor cytotoxicity and achieve consistent and long-lasting clinical response. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to advance next-generation CAR T-cell therapies, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency.
The preferred location for this role is hybrid based out of our South San Francisco, CA office.
POSITION SUMMARY:
The incumbent is responsible for formulating an integrated vision and strategy for communicating effectively with the investor community resulting in positive brand recognition and strong investor interest in Lyell. The Director or Senior Director, Investor Relations and Communications ensures that the Company’s scientific and clinical development strategy and progress are clearly communicated to investors, analysts, media, and the broad financial community. The person in this role must translate complex technical data into investment-driving narratives. Collaboration with executives and product teams on the delivery of external communications and corporate initiatives is essential to optimize the story of Lyell and its advances in science with investors, media, and industry organizations to broaden awareness and the brand of Lyell. Key duties include helping to develop and manage press releases, the corporate website, quarterly earnings filings, organizing conferences/roadshows, optimizing the corporate deck, determining corporate milestones to be communicated externally, and ensuring regulatory compliance.
KEY ROLE AND RESPONSIBILITIES:
- Collaborate with the C-suite and product teams to develop and execute a
communications strategy to share the importance of Lyell with investors via quarterly
filings, conference calls, investor conferences, and roadshows; - Ensure that there is effective and consistent execution on the corporate communications
strategy to ensure optimal outreach to investors and analysts to keep Lyell’s strategy
and progress top of mind; - Lead, develop and execute a comprehensive, strategic communications strategy and
tactical plan to achieve key investor relations objectives; evolve as needed; - Partner with Finance and Legal to ensure investor-facing communications are robust,
timely and accurate, and provide compelling messaging and information. - Develop written materials, such as key messages, FAQs and talking points to effectively
communicate the company’s positioning, decision, or program updates for conference
calls and other investor/analysts events. - Train, advise, and develop spokespeople for media interviews, press conferences, and
industry presentations; prepare talking points and briefing documents, as needed. - Leverage existing network and build strong relationships with analysts, investors,
members of the press, influencers, and partners, including serving as an on-record
spokesperson, per the external communications strategy; - Partner with media, identified PR agency, and external partners as needed to develop
and execute campaigns, outreach programs, and monitor brand activity. - Maintain a thorough understanding of our corporate strategy and the importance of each
stakeholder segment to our corporate and scientific portfolio and messaging. - Manage daily proactive and responsive communications for the company, including
devising a crisis communications strategy and rapid response efforts. - Keep track of the developments and public announcements by our competitors and peer
companies.
PREFERRED EDUCATION:
- Bachelor’s Degree in a Scientific discipline preferred; Communications, Marketing, or
related field considered with significant biotech industry experience - Master’s Degree a plus
PREFERRED EXPERIENCE:
- Senior Director -
- Minimum 10 years’ experience in public relations (preferably investor relations),
corporate communications, or media with a strong understanding of business needs and
competitive challenges in the life science industry. Minimum 8 years’ experience in management and leadership roles in mid to large size
organizations.
- Minimum 10 years’ experience in public relations (preferably investor relations),
- Director -
- Minimum 7-9 years’ experience in public relations (preferably investor relations),
corporate communications, or media with a strong understanding of business needs and
competitive challenges in the life science industry. Minimum 5-7 years’ experience in management and leadership roles in mid to large size
organizations.
- Minimum 7-9 years’ experience in public relations (preferably investor relations),
- Experience in the biotech industry in investor relations and corporate communications or
as sell-side analyst. - Effective track record in managing investor relations strategy and supporting significant
initiatives such as financing, conference participation, and product launches. - Proven written and verbal communication strength with the ability to tailor messages to a
diverse set of audiences and define the various voices of Lyell (internal, external, etc.). - Strong, proven executive leadership experience with business/corporate development or
operations familiarity.
KNOWLEDGE, SKILLS AND ABILITIES:
- Cross-functional experience leading through complexity, with the ability to influence and
collaborate with multiple stakeholders at all levels across functions and levels. - Strong executive presence with the ability to lead executive discussions, focus on detail
and think strategically. - Collaborative leadership style.
- Track record of prioritizing and executing competing priorities in a fast-moving
environment. - Willingness to “roll-up your sleeves” managing a diverse set of objectives, shifting fluidly
from strategy to execution consistent with a start-up environment. - Agile and creative thinker in external communications; uses sound judgement.
Similar jobs
Est. 240,000 USD
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However,…
Est. 255,000 USD
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However,…
Est. 210,000 USD
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However,…
Est. 270,000 USD
The Director, Clinical Development will serve as a key clinical contributor embedded in Lyell's small, high-impact development team. This individual contributor role is responsible for providing medical and scientific le…
Est. 210,000 USD
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However,…
Est. 235,000 USD
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However,…
Est. 347,500 USD
Lyell Immunopharma is a clinical-stage biopharmaceutical company developing next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors. As Lyell advances toward BLA submission and co…
Est. 167,500 USD
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However,…
Est. 108,000 USD
The Quality Assurance Specialist provides QA oversight for Facility, Equipment, Utility (FEU), and Computer System (CS) programs in a cell therapy manufacturing environment, with accountability for review, approval, esca…
Est. 194,416 USD
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However,…
Est. 93,600 USD
The Quality Assurance team is seeking a highly motivated and detail-oriented Quality Assurance Senior Associate to join our team at the Lyell Manufacturing Facility, LyFE in Bothell WA. This individual will perform routi…
Est. 155,000 USD
What if you could join a rapidly growing company and play a critical role in bringing new medicines to patients through looking at and treating disease in a revolutionary way. What this position is all about: Are you a h…
Est. 263,500 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 188,000 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 260,000 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 165,000 USD
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medic…
Est. 224,000 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 223,883 USD
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy throug…
Est. 140,000 USD
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy throug…
Est. 214,000 USD
What if you could join a rapidly growing company and play a critical role in bringing new medicines to patients through looking at and treating disease in a revolutionary way. What this position is all about: What if you…
Est. 391,571 USD
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy throug…
Est. 250,000 USD
Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medic…
Est. 442,000 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 258,000 USD
At Veracyte, we offer exciting career opportunities for those interested in joining a pioneering team that is committed to transforming cancer care for patients across the globe. Working at Veracyte enables our employees…
Est. 178,000 USD
At Veracyte, we offer exciting career opportunities for those interested in joining a pioneering team that is committed to transforming cancer care for patients across the globe. Working at Veracyte enables our employees…
Est. 199,000 USD
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress…
Est. 375,000 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 212,500 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 285,000 USD
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitmen…
Est. 277,500 USD
“Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) a…